Close this window

MR in Drug Research Study Group
Wednesday, 10 May 2006

Room 611 - 612
19:30 - 21:30

Last updated 31 July 2008

19:30 Business Meeting
19:40 Scientific Meeting:  “Current Status of MRI in Drug Discovery”
  19:45   Potential Uses of Magnetic Resonance Imaging in Development of Therapies for Atheroma
              Zahi A. Fayad, The Eva and Morris Feld Cardiovascular MRI Research Laboratory, Mount Sinai School of Medicine,
              New York, New York, USA
  20:10   Applications of MRI in the Development of Drugs for Musculoskeletal Disorders
              John Waterton, Discovery Enabling Capabilities & Sciences, AstraZeneca, Alderly Edge, United Kingdom
  20:35   MRI in the Development of Drugs for Neurological Disorders: An Industry View
              Paul Matthews, GlaxoSmithKline, London, England, UK
  21:00   Biomarker Consortium Update
              Jeffrey L. Evelhoch, Medical Sciences – Imaging, Amgen, Inc., Thousand Oaks, California, USA
  21:15   Panel Discussion